Related Experiment Video
Updated: May 7, 2026
Biomimetic Materials to Characterize Bacteria-host Interactions
Published on: November 16, 2015
Successful Repeated Use of a Pathogen Adsorbing Biomimetic Device for the Adjunct Treatment of a SARS-CoV-2
Reuben Okioma1, Khalida Soki2, Alexander Hay3
1Department of Critical Care, The Nairobi Hospital, Nairobi, Kenya.
Introduction:
The Seraph® 100 Microbind® Affinity Filter is a biomimetic adsorbent device that can remove pathogens from the blood.
Case Presentation:
Here, we report the successful use of the Seraph® 100 to treat both a SARS-CoV-2 reinfection leading to severe COVID-19 pneumonia as well as subsequent secondary lung infections including Acinetobacter baumannii, Serratia marcescens, and Pseudomonas aeruginosa multidrug-resistant bacteria. To our knowledge, this 46-year-old black male is the first patient in which four treatments with this pathogen adsorber, one for a viral and three for different bacterial infections, have been successfully used.
Conclusion:
The Seraph® 100 can be easily and successfully used in conjunction with standard (anti-infective) treatment.
